Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2003
08/27/2003EP1337543A1 Streptavidin-binding peptides and uses thereof
08/27/2003EP1337282A2 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor
08/27/2003EP1337276A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
08/27/2003EP1337242A2 Gene delivery formulations and methods for treatment of ischemic conditions
08/27/2003EP1259597A4 Zinc finger domains and methods of identifying same
08/27/2003EP1252325A4 Compositions and methods for inhibition of hiv-1 infection
08/27/2003EP1187921A4 Compositions affecting programmed cell death and their use in the modification of forestry plant development
08/27/2003EP1124577B1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS
08/27/2003EP1061935A4 Proapoptotic peptides, dependence polypeptides and methods of use
08/27/2003EP0942740B1 Combination therapy using a tnf binding protein for treating tnf-mediated diseases
08/27/2003EP0870199A4 Assays for growth hormone secretagogue receptors
08/27/2003EP0832132B1 Lymphocyte chemoattractant factor and uses thereof
08/27/2003EP0821693B1 Novel human cytomegalovirus dna sequences
08/27/2003EP0760685B1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
08/27/2003EP0750458B1 Terminal complement inhibitor fusion genes and proteins
08/27/2003EP0706566B1 Conotoxins having acetylcholine receptor binding properties
08/27/2003CN1439053A Non-endogenous, constitutively activated hyman G protein-coupled receptors
08/27/2003CN1439052A Polypeptides, use thereof and process for producing the same
08/27/2003CN1439051A DNA sequences encoding dystrophin minigenes and methods of use thereof
08/27/2003CN1439021A Parathyroid hormone and parathyroid hormone-related protein receptor modulators
08/27/2003CN1439020A Biosynthetic oncolytic molecules and uses therefor
08/27/2003CN1439019A Anti-freeze proteins, their production and use
08/27/2003CN1439017A Novel compounds
08/27/2003CN1438896A Vaccine comprising a tick cement protein
08/27/2003CN1438895A Peptide composition
08/27/2003CN1438894A Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking LFA-1 medicated adhesion
08/27/2003CN1438316A Method for expressing human's egg transparent band 2P3 protein in saccharomycetes expression system
08/27/2003CN1438243A Method for preparing fiberbound protein
08/27/2003CN1438242A Systhesizing of chimeric peptide from anteron promoted by human's fine hair
08/27/2003CN1438241A Reverse-corelation-resisting signal transfer gene of plant and protein coded thereof
08/27/2003CN1438240A Method for preparing phycocyanin of sea water
08/27/2003CN1438239A Novel fluorescent proteinÒÇüpolynucleotide series coded thereof and use
08/27/2003CN1437957A Method for producing whole silkworm powder milk-containing and ferritin
08/27/2003CN1119421C Recombinant fusion proteins to growth hormone and serum albumin
08/27/2003CN1119416C Human interleukin 2 derivatives and human heart sodium medium fusion gene, its protein products and uts thereof
08/27/2003CN1119353C Modified avidin and streptavidin and use thereof
08/27/2003CN1119352C Express and purification of human serum albumin in pichia
08/27/2003CN1119351C Cyclic adhesion inhibitors
08/27/2003CN1119169C Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof
08/26/2003USRE38240 DNA encoding human endothelial cell growth factors and plasmids comprising said DNA
08/26/2003US6611766 Quantitative and qualitative analysis of immunologically or pathologically affected cells; two dimensional gel electrophoresis; generating master composite image
08/26/2003US6610907 Cotton leaf curl virus (CLCuV) promoter and its use
08/26/2003US6610906 Nucleotide sequences for gene regulation and methods of use thereof
08/26/2003US6610905 Transgenic mouse model for Kaposi's sarcoma
08/26/2003US6610839 Promoter for telomerase reverse transcriptase
08/26/2003US6610838 Isolated nucleic acid encoding polypeptides which bind with a rabbit polyclonal antibody raised against another polypeptide; use in vaccines as well as diagnostic compositions and kits
08/26/2003US6610836 Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics
08/26/2003US6610832 Preserving a hemoglobin blood substitute with a transparent overwrap
08/26/2003US6610830 Microbial production of mature human leukocyte interferons
08/26/2003US6610829 Human extracellular matrix-1
08/26/2003US6610828 Heliothis ecdysone receptor
08/26/2003US6610827 Potassium channel subunit polypeptide and polynucleotide compositions and uses therefor
08/26/2003US6610825 Method for alleviating pain or providing an analgesic effect in a patient
08/26/2003US6610824 Amylin agonist peptides and uses therefor
08/26/2003US6610823 Antigens associated with polymyositis and with dermatomyositis
08/26/2003US6610821 Cyclic peptide of given amino acid sequence; can use to improve drug delivery process, inhibit angiogenesis, increase vasopermeability; treatment of autoimmune and inflammatory diseases
08/26/2003US6610820 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
08/26/2003US6610663 Antisense compound with targeting and RNA cleaving moieties, preferably an imidazole functionality conjugated to the targeting oligonucleotide via linkers
08/26/2003US6610659 Use of heat shock protein 70 preparations in vaccination against cancer and infectious disease
08/26/2003US6610658 Modulators of μ-amyloid peptide aggregation
08/26/2003US6610657 Reducing semen migration using polypeptides which inhibit binding of protein kinases; contraceptives; antifertility agents
08/26/2003US6610656 Activating osteogenesis using hedgehog genes or proteins coded by hybridized nucleic acids
08/26/2003US6610654 Antiproliferative agents selected from hemoglobins and macrophage inflammatory proteins, transforming growth factors, tumor necrosis factors, interferons or peptides; controlling progenitor cells after exposure to radiation or drugs
08/26/2003US6610650 Modulation of cellular transcription factor activity
08/26/2003US6610649 To stimulate Na+K+ATPase activity which has been shown to be reduced in patients with insulin-dependent diabetes mellitus to treat or prevent diabetic neuropathy, nephropathy and retinopathy
08/26/2003US6610536 Nucleic acids and polypeptides
08/26/2003US6610533 A fourth cold shock protein of the Escherichia coli CspA family is disclosed, as are the regulatory elements of the 5' UTR of the corresponding gene. The cspI gene is located at 35.2 min on the E. coli chromosome map, and CspI and mRNA
08/26/2003US6610532 Treating or preventing heart defects in mammals; obtain human, administer modulator, monitor humans for adjustment in heart activity
08/26/2003US6610527 The taxadiene synthase gene of Pacific yew has been cloned and its nucleic acid and polypeptide sequence is presented. Truncation or removal of the transit peptide increases expression of the cloned taxadiene synthase gene expression in
08/26/2003US6610526 Human E1-like protein
08/26/2003US6610523 Human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human MAP kinases p38 and JNK, which result in activation of other factors, including activating
08/26/2003US6610522 Cloned genes encoding reverse transcriptase lacking RNase H activity
08/26/2003US6610517 Compartmentalization of recombinant polypeptides in host cells
08/26/2003US6610515 Medicine which promotes the production of neutrophiles in case the number of the neutrophiles decreases upon treating the tumor of a cat, and does not have side-effects, wherein said medicine is prepared by incorporating, as an active
08/26/2003US6610514 Yeast vector and method of producing proteins using the same
08/26/2003US6610513 Receptor proteins
08/26/2003US6610512 Zinc finger binding domains for GNN
08/26/2003US6610511 Drosophila odorant receptors
08/26/2003US6610510 Human Cerberus proteins and related nucleic acids are provided. Included are proteins comprising a human cerberus domain having specific activity, particularly the ability to antagonize a bone morphogenic protein. The proteins may be
08/26/2003US6610509 Targeted expression by the cartilage- derived retinoic acid-sensitive protein (CD-RAP) promoter. It is also directed to nucleic acid constructs and vectors useful for expression of nucleic acid sequences targeted to cartilage during
08/26/2003US6610508 Translation driver system and methods for use thereof
08/26/2003US6610507 Polynucleotides encoding patched proteins
08/26/2003US6610506 Transferrin binding proteins of Pasteurella haemolytica and vaccines containing same
08/26/2003US6610501 Porcine protein and uses thereof
08/26/2003US6610500 Agonistic anti-human TrkA mAb 5C3 which recognizes the NGF docking site. Such antibodies may be used for the treatment, diagnosis or prevention of neurological diseases, neuromas and neoplastic tumors which express TrkA receptors.
08/26/2003US6610493 Screening compounds for the ability to alter the production of amyloid-β peptide
08/26/2003US6610489 Pharmacogenomics and identification of drug targets by reconstruction of signal transduction pathways based on sequences of accessible regions
08/26/2003US6610485 Kit are provided for selectively isolating genes encoding membrane-bound proteins by fusing proteins to a secretable protein having a binding affinity to an antigen (e.g.an antibody), expressing these fusions in host cells, and
08/26/2003US6610480 Identification of genes which are differentially expressed in hypertrophic cardiac tissue as compared to normal cardiac tissue. Accordingly, the present invention provides nucleotide sequences of genes and promotion or inhibition of the function
08/26/2003US6610479 Enzymes or catalytic fragments thereof reversibly inactivated by attachment to an immobilizing moiety which may comprise a magnetic particle are activated by release from the immobilizing moiety. The enzyme or fragment may be in the form
08/26/2003US6610477 Human DNA mismatch repair proteins
08/26/2003US6610476 Nucleotide sequence of HTLV-III DNA; identification, isolation and expression of HTLV-III sequences which encode immunoreactive polypeptides by recombinant,DNA methods and production of viral RNA are disclosed. Such polypeptides can
08/26/2003US6610475 Kits for processing biological specimens for nucleic acid hybridization assays, target amplification reactions and similar uses
08/26/2003US6610473 Peptides for inhibiting HPV E6-proteins
08/26/2003US6610471 Methods and compositions to investigate infection by hepatitis B virus and agents to prevent and treat the infection
08/26/2003US6610334 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins
08/26/2003US6610307 Immunity against pasteurella haemolytica leukotoxin
08/26/2003US6610306 For therapy, prophylaxis and diagnosis of non-symptomatic gonococcal infection or symptomatic disease and non-symptomatic meningococcal infection and symptomatic disease
08/26/2003US6610305 Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
08/26/2003US6610303 Papilloma viruses, products for the detection thereof as well as for treating diseases caused by them